Global Medical REIT (GMRE) Tops Q1 EPS by 2c, provides guidance

Global Medical REIT (NYSE: GMRE) reported Q1 EPS of $0.03, $0.02 better than the analyst estimate of $0.01. Revenue for the quarter came in at $34.62 million versus the consensus estimate of $35.34 million.

2025 Guidance

The Company is reaffirming its full year 2025 AFFO per share and unit guidance of $0.89 to $0.93. Guidance is based on the following primary assumptions and other factors:

No additional acquisitions or dispositions other than activity that has been either completed or announced.
No additional equity or debt issuances other than normal course Revolver borrowing/repayments.
AFFO guidance excludes one-time obligations related to the CEO succession plan.

For earnings history and earnings-related data on Global Medical REIT (GMRE) click here.

You May Also Be Interested In

• FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
• Pacific Booker Minerals Inc. Adopts Advance Notice Policy for Director Elections
• FedEx (FDX) Tops Q4 EPS by 39c, Beats on Revenue; Offers FY27 EPS Guidance